HIV in Pregnancy | Instant Homework Help

You will prepare and submit a term paper on Research Article Critique: HIV in Pregnancy. Your paper should be a minimum of 3250 words in length. The authors’ research study was to determine whether antiretroviral therapies decrease mother-to-child transmission of HIV. It also sought to determine to what extent the therapies are clinically useful in decreasing transmission risk. The effects of these interventions on infant and maternal mortality and morbidity rates were also examined. My examination focuses systematically on specific areas of the research study article. It will focus on these aspects in terms of the process, validity of the research methods, and results. This study is vital in the sense that it helps in identifying the right combination therapy in suppressing HIV replication. This helps in improving the clinical status and the immune system of children and adults living with HIV/AIDS (Faden, & Kass, 1996). The second article determines the relationship between the vertical transmission of human immunodeficiency virus type 1 (HIV-1) and elective cesarean section. But not all findings in the study are properly done to comprehensively validate the study results. Therefore, there is a need to critically put forth the worth of each study and the evidence provided by the researchers, thus appraising these studies. The title of the study define clearly what the study is all about, that is, to investigate whether antiretroviral therapies decrease the risk of mother-to-child HIV transmission in the first article and to evaluate the relationship between HIV-1 vertical transmission and elective cesarean section in the second article. The study population, a brief description of the methodology and the key outcomes being investigated are all included in the title of the second study: The Mode of Delivery and the Risk of Vertical Transmission of Human Immunodeficiency Virus Type 1 — A Meta-Analysis of 15 Prospective Cohort Studies. This does not apply to the first article: Antiretroviral drugs for reducing risks of mother-to-child HIV infection and transmission.